Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

3.45
-0.0700-1.99%
Post-market: 3.45-0.0050-0.14%19:55 EDT
Volume:743.92K
Turnover:2.58M
Market Cap:280.35M
PE:-3.50
High:3.58
Open:3.54
Low:3.41
Close:3.52
52wk High:4.60
52wk Low:1.35
Shares:81.26M
Float Shares:74.57M
Volume Ratio:0.83
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9867
EPS(LYR):-0.5566
ROE:-110.71%
ROA:-39.02%
PB:3.89
PE(LYR):-6.20

Loading ...

Eledon says Phase 2 BESTOW extension shows higher kidney function with tegoprubart vs tacrolimus at 18 months

Reuters
·
Jun 22

Eledon Presents Long-Term Extension Phase 2 Bestow Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes With Tegoprubart Compared With Tacrolimus

THOMSON REUTERS
·
Jun 22

Noble Financial Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Jun 11

Eledon Pharmaceuticals announces updated results from tegoprubart trial

TIPRANKS
·
Jun 08

Eledon Announces Updated Data From Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients With Type 1 Diabetes (T1d) at Uchicago Medicine

THOMSON REUTERS
·
Jun 08

Eledon says updated tegoprubart islet transplant trial data to be presented at ADA 2026 sessions

Reuters
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Whitehawk Therapeutics (WHWK) and Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
May 22

Eledon presents new long-term Phase 2 BESTOW kidney transplant data for tegoprubart at ATC

Reuters
·
May 21

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 18

LifeSci Capital Remains a Buy on Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
May 14

BRIEF-Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results And Recent Business Highlights

Reuters
·
May 14

Eledon Pharma Q1 EPS $(0.33) Misses $(0.18) Estimate

Benzinga Earnings
·
May 14

Eledon Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 14

Eledon Pharmaceuticals Q1 net loss widens on warrant liability loss

Reuters
·
May 14

Eledon Q1 FY26 net loss widens to $39.03 million

Reuters
·
May 14

Eledon Pharmaceuticals Q1 Net Income USD -39.025 Million

THOMSON REUTERS
·
May 14

Eledon Pharmaceuticals Q1 Basic EPS USD -0.33

THOMSON REUTERS
·
May 14

Press Release: Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights

Dow Jones
·
May 14

Eledon Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 08

Eledon Pharmaceuticals Files $500 Million Mixed Shelf Registration

MT Newswires Live
·
May 02